Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease

Heart

Volumn 100, Issue 17, 2014, Pages 1373-1381

  Balci, Ali ^a,b   Sollie Szarynska, Krystyna M ^b   Van Der Bijl, Antoinette G L ^b   Ruys, Titia P E ^c   Mulder, Barbara J M ^d   Roos Hesselink, Jolien W ^c   Van Dijk, Arie P J ^e   Wajon, Elly M C J ^f   Vliegen, Hubert W ^g   Drenthen, Willem ^b   Hillege, Hans L ^b   Aarnoudse, Jan G ^c   Van Veldhuisen, Dirk J ^b   Pieper, Petronella G ^b  

^a Department of Cardiology Isala ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f MEDISCH SPECTRUM TWENTE   (Netherlands)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIOVASCULAR RISK; CHILD; CONGENITAL HEART DISEASE; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREGNANT WOMAN; PRIORITY JOURNAL; PROGENY; PROSPECTIVE STUDY; SCORING SYSTEM; THROMBOEMBOLISM; WORLD HEALTH ORGANIZATION;

CONGENITAL HEART DISEASE;

AREA UNDER CURVE; DECISION SUPPORT TECHNIQUES; FEMALE; FETAL DEATH; GERMANY; HEART DEFECTS, CONGENITAL; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; MATERNAL MORTALITY; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 84905496777     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2014-305597     Document Type: Article

References (32)

1. Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 2007;49:2303-11. (Pubitemid 46891708)
2. Drenthen W, Boersma E, Balci A, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010;31:2124-32.
3. Fesslova VM, Villa L, Chessa M, et al. Prospective evaluation from single centre of pregnancy in women with congenital heart disease. Int J Cardiol 2009;131:257-64.
4. Jastrow N, Meyer P, Khairy P, et al. Prediction of complications in pregnant women with cardiac diseases referred to a tertiary center. Int J Cardiol. 2010;151:209-13.
5. Khairy P, Ouyang DW, Fernandes SM, et al. Pregnancy outcomes in women with congenital heart disease. Circulation 2006;113:517-24.
6. Ouyang DW, Khairy P, Fernandes SM, et al. Obstetric outcomes in pregnant women with congenital heart disease. Int J Cardiol 2010;144:195-9.
7. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515-21. (Pubitemid 32738118)
8. Siu SC, Colman JM, Sorensen S, et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 2002;105:2179-84. (Pubitemid 34517162)
9. Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart 2006;92:1520-5. (Pubitemid 44578860)
10. Warnes CA, Liberthson R, Danielson GK, et al. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol 2001;37:1170-5.
11. Regitz-Zagrosek V, Blomstrom LC, Borghi C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147-97.
12. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 2008;118:e714-833.
13. Balci A, Sollie KM, Mulder BJM, et al. Associations between cardiovascular parameters and uteroplacental Doppler (blood) fl ow patterns during pregnancy in women with congenital heart disease: Rationale and design of the Zwangerschap bij Aangeboren Hartafwijking (ZAHARA) II study. Am Heart J 2011;161:269-75.
14. Vahanian A, Baumgartner H, Bax J, et al. A. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-68. (Pubitemid 46276943)
15. Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713.
16. Lang RM, Bierig M, Devereux RB, et al . Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
17. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009;22:1-23.
18. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36. (Pubitemid 12142173)
19. McNeil BJ, Hanley JA. Statistical approaches to the analysis of receiver operating characteristic (ROC) curves. Med Decis Making 1984;4:137-50. (Pubitemid 14001462)
20. Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982;115:92-106. (Pubitemid 12205725)
21. Bhatla N, Lal S, Behera G, et al. Cardiac disease in pregnancy. Int J Gynaecol Obstet 2003;82:153-9. (Pubitemid 36842839)
22. Ford AA, Wylie BJ, Waksmonski CA, et al. Maternal congenital cardiac disease: outcomes of pregnancy in a single tertiary care center. Obstet Gynecol 2008;112:828-33.
23. Song YB, Park SW, Kim JH, et al. Outcomes of pregnancy in women with congenital heart disease: a single center experience in Korea. J Korean Med Sci 2008;23:808-13.
24. Curtis SL, Marsden-Williams J, Sullivan C, et al. Current trends in the management of heart disease in pregnancy. Int J Cardiol 2009;133:62-9.
25. Stangl V, Schad J, Gossing G, et al. Maternal heart disease and pregnancy outcome: a single-centre experience. Eur J Heart Fail 2008;10:855-60.
26. Kampman MA, Balci A, van Veldhuisen DJ, et al. N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease. Eur Heart J 2014;35:708-15.
27. Roos-Hesselink JW, Ruys TP, Stein JI, et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J 2013;34:657-65.
28. Ruys TP, Roos-Hesselink JW, Hall R, et al. Heart failure in pregnant women with cardiac disease: data from the ROPAC. Heart 2014;100:231-8.
29. Gelson E, Curry R, Gatzoulis MA, et al. Effect of maternal heart disease on fetal growth. Obstet Gynecol 2011;117:886-91.
30. Uebing A, Arvanitis P, Li W, et al. Effect of pregnancy on clinical status and ventricular function in women with heart disease. Int J Cardiol 2010;139:50-9.
31. Ravelli AC, Eskes M, Tromp M, et al . [Perinatal mortality in The Netherlands 2000-2006; risk factors and risk selection]. Ned Tijdschr Geneeskd 2008;152:2728-33.
32. Pieper PG, Balci A, Aarnoudse JG, et al. Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease. Circulation 2013;128:2478-87.